North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 11 of 11
Details
LDL
Link Added : MHRA Drug Safety Update Nov 2020: Pirfenidone (Esbriet): risk of serious liver injury; updated advice on liver function testing : https://www.gov.uk/drug-safety-update/pirfenidone-esbriet-risk-of-serious-liver-injury-updated-advice-on-liver-f
05/07/2023 14:39:35
(ebeavers )
UPD
sitematrix Changed from 0 to
28/10/2022 14:18:07
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of idiopathic pulmonary fibrosis in line with NICE and NHS England Commissioning Policy
to
Approved for the treatment of idiopathic pulmo
28/10/2022 14:18:07
(DavidS )
UPD
Pirfenidone brand name removed in anticipation of generics being used
28/10/2022 14:18:07
(DavidS )
UPD
Published from Draft Mode
09/05/2018 10:54:11
(LoweryM )
UPD
Pirfenidone (EsbrietŪ) updated guidance with newly approved NICE TA504 (April 2018)
27/04/2018 13:05:07
(DavidS )
UPD
Pirfenidone (EsbrietŪ) b
27/01/2017 10:22:35
(WhitehallJ )
UPD
Pirfenidone b
27/01/2017 10:21:34
(WhitehallJ )
UPD
Pirfenidone b
17/01/2017 11:47:31
(LoweryM )
UPD
Pirfenidone build
30/12/2016 15:11:29
(DavidS )
UPD
pirfenidone Build
24/11/2016 15:53:24
(ClarkH )